Fifth Third Bancorp’s RxSight RXST Stock Holding History

Fifth Third Bancorp’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-24	Closed	-$116	–	4475
2026 Q2	$116	Hold	24	–	–	﹤0.01%	4303
2026 Q1	$148	Buy	+24	New	+$199	﹤0.01%	4257

Other funds holding RXST

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Carnegie Lake Advisors Princeton, New Jersey $271M AUM 17.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nations Financial Group Cedar Rapids, Iowa $2.01B AUM 24.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Lake Street Private Wealth Chicago, Illinois $908M AUM 20.93% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return

Brighton Jones LLC Seattle, Washington $5.73B AUM 24.99% 1-Year Est. Return

Fifth Third Bancorp's RXST Position: Q3 2026 in Review

Fifth Third Bancorp sold out of RxSight (RXST) in Q3 2026, closing a stake of 24 shares — an estimated $116 sold.

Fifth Third Bancorp first reported a position in RXST in Q1 2026 and held it in 2 quarters. The position peaked at $148 in Q1 2026. 34 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

Fifth Third Bancorp reported no remaining RxSight position as of Q3 2026 after selling out during the quarter.
Fifth Third Bancorp sold 24 RxSight shares in Q3 2026, an estimated $116.
Fifth Third Bancorp first reported a position in RxSight in Q1 2026 and held it in 2 quarters.
Fifth Third Bancorp's RxSight position peaked at $148 in Q1 2026.
34 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Fifth Third Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.